Rheumatology Medical News

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial
Annals of Rheumatic Diseases, 11/10/09

Hartkamp A et al. – Our trial does not indicate an effect of daily 200 mg oral DHEA on fatigue and well-being and therefore DHEA treatment is not recommended in unselected female patients with quiescent SLE.

Methods

Double-blind, randomized, placebo-controlled study
60 female patients with inactive SLE received 200 mg oral DHEA or placebo
Primary outcome measures general fatigue, depressive mood, mental well-being, and physical functioning
Assessments were before treatment, after 3, 6, and 12 months on medication, and 6 months after cessation of treatment

Results

Patients from both DHEA and placebo group improved on general fatigue and mental well-being
No differential effect of DHEA
Belief to have used DHEA was a stronger predictor for improvement of general fatigue than the actual use of DHEA

<< Previous
Dynamics of body composition and bone in patients with juvenile...

Next >>
Sinus aspergilloma in rheumatoid arthritis before or during tumor...